Executive Summary
Astrazeneca filed a suit seeking permanent injunction against Everest Pharmaceuticals for infringing its patent IN 297581, which covers the compound Osimertinib. The court found that the plaintiffs made out a prima facie case and granted an ad interim ex-parte injunction restraining the defendants from manufacturing or selling the infringing product until further hearing.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Astrazeneca Ab vs Everest Pharmaceuticals Limited is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Rspl Health Private LimitedvsReckitt And Colman Overseas Hygiene Home Ltd.
This Delhi High Court order addresses an infringement suit filed by Rspl Health Private Limited against Reckitt And Colman Overseas Hygiene Home Ltd. The plaintiff alleged that the defendant's use of 'XPERT' in its registered word mark, 'HARPIC DRAIN XPERT,' infringed upon the plaintiff's device mark registration. While the court acknowledged the merits of the dispute, it primarily issued procedural directions, allowing the suit to proceed and setting timelines for filing written statements and interim replies.
J. Nageswara RaovsThe State Of Madras
The petitioner challenged the classification of his patented medicine, 'Vitogen', as 'medicated wine' and the associated duties levied under the Madras Prohibition Act. The court examined the scope of the Act and various notifications regarding medicinal preparations. While upholding the liability of 'Vitogen' to pay a specific duty (Rs. 35 per proof gallon) under Notification No. 473, the court declared certain provisions of the Act, including Section 23(2) and Notification No. 941, as ultra vires and unenforceable.
Burger King Company LlcvsRanjan Gupta & Ors.
The Delhi High Court affirmed the strong standing of Burger King Company LLC, declaring its trademark 'BURGER KING' to be well-known in India. The court relied on extensive global usage, massive promotional investment, and local market presence (over 400 outlets) to establish secondary meaning. This ruling significantly strengthens the brand's protection against unauthorized use by defendants operating under similar names like 'Burger King Family Restaurant'.
Shrinath Travel Agency Through Its Partners & Anr.vsHarsh Kumar Trading As Shrinath Nama Travel Agency & Ors.
The Delhi High Court allowed the Plaintiffs to implead several additional defendants in a trademark infringement suit. Finding a prima facie case of deception due to identical or deceptively similar marks being used for identical travel services, the court granted an interim injunction restraining the newly added parties from using the impugned trademarks. Furthermore, the court directed domain registrars associated with infringing websites to block and suspend access to those domains.
M/S. P.M. Diesels P. Ltd.vsM/S. Thukral Mechanical Works & Ors.
The Delhi High Court delivered a multi-faceted judgment addressing several IP disputes involving the 'FIELDMARSHAL' trademark. In one suit, the court decreed P.M. Diesels Pvt. Ltd.'s claim against Thukral Mechanical Works, while simultaneously ordering the cancellation of an older registration held by Thukral Mechanical Works in Class 7. Furthermore, the High Court set aside previous rejection orders for P.M. Diesels' trademark applications, allowing them to proceed toward registration.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.